Literature DB >> 14641872

Mutations in GYPB exon 5 drive the S-s-U+(var) phenotype in persons of African descent: implications for transfusion.

Jill R Storry1, Marion E Reid, Susan Fetics, Cheng-Han Huang.   

Abstract

BACKGROUND: The S-s-U- phenotype in African Americans is due to a GYPB deletion, however the molecular basis for the S-s-U+var phenotype is poorly understood. Variable reactivity of S-s-U+var RBCs with monoclonal anti-He or by anti-U has been demonstrated, however the underlying molecular bases for this phenotype remain to be established. STUDY DESIGN AND METHODS: Hemagglutination was performed on 104 S-s- blood samples using monoclonal anti-He and anti-U. GYPB was sequenced from selected samples. Allele and exon-specific PCR analysis was used to identify wild-type and mutant alleles.
RESULTS: The RBCs of 49-percent S-s- samples were identified as S-s-U+var by hemagglutination. Sequencing analysis of 41 samples revealed 1) a point mutation at +5 (g > t) of intron 5 that resulted in skipping of exon 5 in 34 samples; 2) two mutations (208G > T and 230C > T) caused partial skipping of exon 5 in four samples due to activation of a cryptic 3' splice site that resulted from a C > G transversion at nt251 present in all GYPB*S alleles and most GYPB*s alleles tested. Three samples were heterozygous for the mutated alleles. DISCUSSION: The S-s-U+var phenotype arises from changes in or around GYPB exon 5. The weak expression of U and in most examples, He, may be due to low levels of normal transcription of the variant gene or to posttranscriptional down regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641872     DOI: 10.1046/j.0041-1132.2003.00585.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use.

Authors:  Julie Di Cristofaro; Monique Silvy; Jacques Chiaroni; Pascal Bailly
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

2.  Applications and Experience with PCR-Based Assays to Predict Blood Group Antigens.

Authors:  Marion E Reid
Journal:  Transfus Med Hemother       Date:  2009-06       Impact factor: 3.747

Review 3.  DNA-based methods in the immunohematology reference laboratory.

Authors:  Marion E Reid; Gregory A Denomme
Journal:  Transfus Apher Sci       Date:  2011-01-22       Impact factor: 1.764

4.  Integration of red cell genotyping into the blood supply chain: a population-based study.

Authors:  Willy A Flegel; Jerome L Gottschall; Gregory A Denomme
Journal:  Lancet Haematol       Date:  2015-07       Impact factor: 18.959

Review 5.  Transfusion in the age of molecular diagnostics.

Authors:  Marion E Reid
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 6.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

7.  Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Authors:  Brigitte Katharina Flesch; Vanessa Scherer; Burkhard Just; Andreas Opitz; Oswin Ochmann; Anne Janson; Monika Steitz; Thomas Zeiler
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

8.  Population genetics of GYPB and association study between GYPB*S/s polymorphism and susceptibility to P. falciparum infection in the Brazilian Amazon.

Authors:  Eduardo Tarazona-Santos; Lilian Castilho; Daphne R T Amaral; Daiane C Costa; Natália G Furlani; Luciana W Zuccherato; Moara Machado; Marion E Reid; Mariano G Zalis; Andréa R Rossit; Sidney E B Santos; Ricardo L Machado; Sara Lustigman
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

9.  Molecular analysis of the GYPB gene to infer S, s, and U phenotypes in an admixed population of Minas Gerais, Brazil.

Authors:  Marina Alves Faria; Marina Lobato Martins; Luciana Cayres Schmidt; Maria Clara Fernandes da Silva Malta
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.